Product dossierBuilt from registrations, label text and platform-curated data
NatrelleNatrelle 410 Highly Cohesive Silicone-Filled Breast Implants
Natrelle is a Breast implant product (Class III device), registered by Allergan. Linked registrations: US P040046, US P020056. First approved in US on 2013-02-20 (P040046). Data as of 2026-11-09.
- Regulatory classBreast implant · Class III device
- HolderAllergan
- JurisdictionsUS
- Updated2026-11-09 · v1
Registration and basics are public; findings and prices need an account
Registration and basics
Label facts by jurisdiction
What each jurisdiction's label says for the same attribute; gaps are marked Not reported, irrelevant ones N/A
No data yet
Registration timeline
- US
P020056 first approved
- US
P040046 first approved
- US
P040046 · P040046/S026
30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|Implement an Electronic Data Acquisition (EDA) System to collect cy…
- US
P040046 · P040046/S027
135 Review Track For 30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|Approval to implement an additional incoming s…
- US
P040046 · P040046/S029
30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|Replace paper chart recorders and to use an electric heating module…
- US
P040046 · P040046/S030
30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|Implementing changes to the gel filling process, specifically, chan…
- US
P040046 · P040046/S032
30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|Addition of an alternative detection method for the Quality Control…
- US
P040046 · P040046/S031
Normal 180 Day Track No User Fee|Postapproval Study Protocol|Approval of the revised protocol for the post-approval study (PAS) protocol.
- US
P020056 · P020056/S059
Real-Time Process|Labeling Change - Indications/instructions/shelf life/tradename|Approval for modifications to Physician and Patient Labeli…
- US
P020056 · P020056/S061
Normal 180 Day Track No User Fee|Labeling Change - PAS|Approval for including the final results from the BIFS-001 NBIR-Arm Clinical Study in…
- US
P020056 · P020056/S063
30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|The 30 Day notice is to notify FDA of the commissioning of the new …
- US
P020056 · P020056/S050
Normal 180 Day Track No User Fee|Postapproval Study Protocol|acknowledgement of a submission that includes the BIFS-001: BIFS-arm Final Stud…
- US
P020056 · P020056/S065
30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|changes to the adhesive coating that is used to secure the lids to …
- US
P020056 · P020056/S064
Normal 180 Day Track No User Fee|Labeling Change - PAS|approval for revised labeling to include the results of the BIFS Arm study.
First approval, this certificate's issue date (updated after renewals or changes), changes and expiry are listed separately; a missing first approval means it was not obtained from an official source. Up to 6 recent changes per registration; click the number for the full record. Dates on non-Chinese registrations keep the source's wording: UK devices show the registration date (MHRA does not approve them), Australia the ARTG start date, FDA devices the decision date.
Cross findings · Price observations
Recent changes
5- P020056: Normal 180 Day Track No User Fee|Labeling Change - PAS|approval for revised labe…2026-09-29
- P020056: 30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|changes…2024-12-16
- P020056: Normal 180 Day Track No User Fee|Postapproval Study Protocol|acknowledgement of …2024-08-16
- P020056: 30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|The 30 …2024-06-21
- P020056: Normal 180 Day Track No User Fee|Labeling Change - PAS|Approval for including th…2023-07-12